Detailed Information on Publication Record
2014
Haematopoietic developmental potential of human pluripotent stem cell lines
TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL and Irena KRONTORÁD KOUTNÁBasic information
Original name
Haematopoietic developmental potential of human pluripotent stem cell lines
Authors
TESAŘOVÁ, Lenka (203 Czech Republic, belonging to the institution), Pavel ŠIMARA (203 Czech Republic, belonging to the institution), Stanislav STEJSKAL (203 Czech Republic, belonging to the institution) and Irena KRONTORÁD KOUTNÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Folia biologica, Praha, Univerzita Karlova, 2014, 0015-5500
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.000
RIV identification code
RIV/00216224:14330/14:00073970
Organization unit
Faculty of Informatics
UT WoS
000343275800015
Keywords (in Czech)
lidské pluripotentní kmenové buňky; hematopoetický vývoj; embryoidní tělíska; CD34+ buňky
Keywords in English
human pluripotent stem cells; hematopoietic development; embryoid bodies; CD34+ cells
Tags
Změněno: 2/3/2018 10:06, Mgr. Pavel Šimara, Ph.D.
Abstract
V originále
The generation of hematopoietic progenitors from human pluripotent stem cells (hPSCs) presents great promise for cell-replacement therapies. However, current protocols for hematopoietic differentiation of hPSCs suffer from low efficiency and functional defects in the derived cells. The technology is also limited by variable ability of hPSC lines to generate blood cells in vitro. To address this issue, methodologies for hematopoietic differentiation in feeder-free conditions were applied to available human embryonic stem cell (hESC) and human induced pluripotent stem cell (hiPSC) lines in this study. It was found that these cell lines did not generate hematopoietic progenitors in such an extent as H1 and H9 hESC lines used for this purpose in the vast majority of relevant studies. These results suggest that for clinical application of blood cells derived from hPSCs, possibly from autologous hiPSCs, it is necessary to overcome the variability in the hematopoietic developmental potential of individual hPSC lines.
Links
CZ.1.07/2.3.00/30.0030, interní kód MU |
| ||
GBP302/12/G157, research and development project |
|